S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BPTH Bio Path Holdings Inc

2.60

-0.06 (-2.26%)

Last Updated: 12:55:14

Delayed by 15 minutes

Bio-Path stock soars on U.S. patent grant

To read the full story on Seeking Alpha, click here.

Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Bio Path Charts.

Bio Path (NASDAQ:BPTH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Bio Path Charts.

Bio Path Holdings Inc News

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Friday 19 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Thursday 18 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Thursday 18 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Bio-Path Holdings Expands Global Patent Portfolio
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Bio-Path Holdings Provides 2024 Clinical and Operational Update
Tuesday 2 April 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Bio-Path Holdings Reports Full Year 2023 Financial Results
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

U.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices Dip
Friday 8 March 2024 (2 months ago) • IH Market News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

More Bio Path Holdings Inc News Articles

RespireRx Pharmaceuticals (PK)

Brookmount Explorations (PK)

Global Developments (PK)

Voip Pal Com (QB)

MicroCloud Hologram

Yuenglings Ice Cream (PK)

Auto Parts 4Less (PK)

Bell Buckle (PK)

Globestar Therapeutics (PK)

Elite Pharmaceuticals (QB)

NaturalShrimp (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions